For help on how to get the results you want, see our search tips.
35 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Referrals Remove Referrals filter
Referral type
Article 107i procedures Remove Article 107i procedures filter
Articles 39 and 40 Remove Articles 39 and 40 filter
Article 6(13) referrals (prior to January 2010) Remove Article 6(13) referrals (prior to January 2010) filter
Article 13 referrals Remove Article 13 referrals filter
Article 107 procedures (prior to July 2012) Remove Article 107 procedures (prior to July 2012) filter
Referral status
European Commission final decision Remove European Commission final decision filter
CMDh final position Remove CMDh final position filter
Categories
Human Remove Human filter
-
List item
Referral: Pholcodine-containing medicinal products (updated)
pholcodine, Article 107i procedures
Status: European Commission final decision, opinion/position date: 14/12/2022, EC decision date: 06/03/2023, Last updated: 22/03/2023 -
List item
Referral: Hydroxyethyl starch (HES) containing medicinal products
hydroxyethyl starch, Article 107i procedures
Status: European Commission final decision, opinion/position date: 26/10/2017, EC decision date: 17/07/2018, Last updated: 11/02/2022 -
List item
Referral: Basiron AC and associated names
benzoyl peroxide, Article 13 referrals
Status: European Commission final decision, opinion/position date: 28/03/2019, EC decision date: 04/07/2019, Last updated: 19/07/2019 -
List item
Referral: Fenspiride containing medicinal products
fenspiride, Article 107i procedures
Status: CMDh final position, opinion/position date: 29/05/2019, Last updated: 26/06/2019 -
List item
Referral: Cardioxane
dexrazoxane, Article 13 referrals
Status: European Commission final decision, opinion/position date: 19/07/2017, EC decision date: 19/07/2017, Last updated: 26/07/2017 -
List item
Referral: Levonelle 1500 microgram tablets and associated names
levonorgestrel, Article 13 referrals
Status: European Commission final decision, opinion/position date: 26/05/2016, EC decision date: 01/08/2016, Last updated: 09/08/2016 -
List item
Referral: Oxynal Targin and associated names
oxycodone hydrochloride, naloxone hydrochloride, Article 13 referrals
Status: European Commission final decision, opinion/position date: 23/10/2014, EC decision date: 22/12/2014, Last updated: 27/01/2015 -
List item
Referral: Methadone medicinal products for oral use containing povidone
methadone, Article 107i procedures
Status: CMDh final position, opinion/position date: 23/07/2014, Last updated: 04/08/2014 -
List item
Referral: Hydroxyethyl starch solutions for infusion
hydroxyethyl starch, Article 107i procedures
Status: European Commission final decision, opinion/position date: 23/10/2013, EC decision date: 19/12/2013, Last updated: 06/03/2014 -
List item
Referral: Flupirtine-containing medicines
flupirtine, Article 107i procedures
Status: European Commission final decision, opinion/position date: 26/06/2013, EC decision date: 05/09/2013, Last updated: 21/11/2013 -
List item
Referral: Octagam
human normal immunoglobulin, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 23/09/2010, EC decision date: 04/10/2010, Last updated: 18/11/2013 -
List item
Referral: Numeta G13%E and Numeta G16%E emulsion for infusion
Article 107i procedures
Status: CMDh final position, opinion/position date: 18/09/2013, Last updated: 27/09/2013 -
List item
Referral: Cyproterone- and ethinylestradiol-containing medicines
cyproterone, ethinyl estradiol, associated names: Acnemine, Acneson, Chloe, Clairette, Cyprest, Cyprodiol, Diane 35, Dianette, Feminil, Minerva, Zyrona, Article 107i procedures
Status: European Commission final decision, opinion/position date: 29/05/2013, EC decision date: 25/07/2013, Last updated: 05/08/2013 -
List item
Referral: Tetrazepam-containing medicines
tetrazepam, associated names: Myolastan and generics, Article 107i procedures
Status: European Commission final decision, opinion/position date: 24/04/2013, EC decision date: 29/05/2013, Last updated: 18/07/2013 -
List item
Referral: Kantos Master
beclometasone dipropionate, formoterol fumarate, associated names: Kantos, Formodual, Foster, Inuxair, Innovair and associated names, Article 13 referrals
Status: European Commission final decision, opinion/position date: 17/01/2013, EC decision date: 10/04/2013, Last updated: 02/05/2013 -
List item
Referral: Buflomedil
buflomedil, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 17/11/2011, EC decision date: 13/02/2012, Last updated: 13/06/2012 -
List item
Referral: Meprobamate
meprobamate, associated names: Equanil and other trade names, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 19/01/2012, EC decision date: 30/03/2012, Last updated: 08/06/2012 -
List item
Referral: Somatropin
somatropin, associated names: Genotropin, Humatrope, Maxomat, Norditropin, Saizen, Zomacton, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 15/12/2011, EC decision date: 27/02/2012, Last updated: 23/04/2012 -
List item
Referral: Norditropin
somatropin, associated names: Norditropin FlexPro, Norditropin NordiFlex, Norditropin SimpleXx, Article 13 referrals
Status: European Commission final decision, opinion/position date: 15/12/2011, EC decision date: 06/03/2012, Last updated: 19/04/2012 -
List item
Referral: Bufexamac
bufexamac, associated names: Parfenac, Bufal, Calmaderm, Fansamac, Mastu S, Parfenoide, Proctosan, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 22/04/2010, EC decision date: 27/07/2010, Last updated: 10/11/2011 -
List item
Referral: Ketoprofen topical
ketoprofen, associated names: Fastum, Ketum, Orudis, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 22/07/2010, EC decision date: 29/11/2010, Last updated: 28/10/2011 -
List item
Referral: Benfluorex
benfluorex, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 18/03/2010, EC decision date: 14/06/2010, Last updated: 27/07/2011 -
List item
Referral: Iodocasein- and thiamine-containing medicinal products
iodocasein, thiamine nitrate, associated names: Antiadiposo, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 10/10/2009, Last updated: 27/05/2011 -
List item
Referral: Sibutramine
sibutramine, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 21/01/2010, EC decision date: 06/08/2010, Last updated: 09/03/2011 -
List item
Referral: Seroquel XR
quetiapine, Article 6(13) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 22/04/2010, EC decision date: 26/08/2010, Last updated: 19/11/2010